US Edition
Philadelphia InquirerSunday, 26 April 2026
Click image to view full size
Thousands left out of reworked opioid accord
Purdue Pharma says its $7.4 billion bankruptcy deal "meaningfully compensates" victims. A review shows fewer than half will see payments.
The paper presents a data-driven investigation into the shortfall of the Purdue Pharma bankruptcy deal, anchoring systemic legal issues in a local human-interest narrative.
The Purdue Pharma bankruptcy settlement is meant to compensate victims of the OxyContin opioid crisis. This review highlights that legal and bureaucratic mechanisms are resulting in a majority of affected individuals being excluded from financial relief.
“fewer than half will see payments”
“Investigative and locally focused”
A WHOLE NEW BALLGAME
At age 63, former Phillie Lenny Dykstra is trying to rebuild his life. He says it starts with finding "the best teammate ever."
Profiles former baseball player Lenny Dykstra's attempts at rehabilitation and religious conversion.
A church unnerved by Trump's attacks on Pope Leo
At St. John the Evangelist in Center City, both priest and parishioners spoke of discomfort and disrespect.
Examines the local parish-level impact of national political rhetoric directed at Catholic leadership.
More from Philadelphia Inquirer
Front page image reproduced for the purpose of critical review and commentary — about our editorial use.